Traws Pharma
TRAW
TRAW
11 hedge funds and large institutions have $3.8M invested in Traws Pharma in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 10 reducing their positions, and 18 closing their positions.
Holders
11
Holders Change
-18
Holders Change %
-62.07%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
10
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Bank of America
Charlotte,
North Carolina
|
$12.6K |
Top Sellers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$157K |
2 |
O
2
OrbiMed
New York
|
$3.56M |
3 |
3
BlackRock
New York
|
$58.5K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$3.7K |
5 |
5
Morgan Stanley
New York
|
$4.29K |